{"altmetric_id":4692659,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["BIND Therapeutics","BIND Biosciences"],"first_seen_on":"2015-10-28T14:58:11+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1406299435,"links":["http:\/\/clinicaltrials.gov\/show\/NCT01300533","http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01300533"],"nct_id":"NCT01300533","pubdate":"2011-02-17T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer","type":"clinical_trial_study_record"},"altmetric_score":{"score":8.024,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":8.024},"context_for_score":{"all":{"total_number_of_other_articles":5380062,"mean":6.2867144781458,"rank":697008,"this_scored_higher_than_pct":87,"this_scored_higher_than":4682574,"rank_type":"exact","sample_size":5380062,"percentile":87},"similar_age_3m":{"total_number_of_other_articles":197042,"mean":10.272260128603,"rank":35654,"this_scored_higher_than_pct":81,"this_scored_higher_than":161385,"rank_type":"exact","sample_size":197042,"percentile":81},"this_journal":{"total_number_of_other_articles":14417,"mean":7.1151786903441,"rank":1943,"this_scored_higher_than_pct":86,"this_scored_higher_than":12473,"rank_type":"exact","sample_size":14417,"percentile":86},"similar_age_this_journal_3m":{"total_number_of_other_articles":766,"mean":10.898614379085,"rank":93,"this_scored_higher_than_pct":87,"this_scored_higher_than":673,"rank_type":"exact","sample_size":766,"percentile":87}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}}},"geo":{"twitter":{"CA":1}}},"counts":{"total":{"posts_count":2},"blogs":{"unique_users_count":1,"unique_users":[52470],"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["j4k0"],"posts_count":1}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/j4k0\/status\/492681659704041474","license":"datasift","citation_ids":[4692659],"posted_on":"2014-07-25T14:43:55+00:00","author":{"name":"j4k0","image":"https:\/\/pbs.twimg.com\/profile_images\/1763298241\/70c493a1-f4b6-4299-bf80-688d3aa3e20a_normal.png","description":"Javier\/30\/H Gamer, Proooooooo-novato xD","id_on_source":"j4k0","tweeter_id":"14615964","geo":{"lt":46.81228,"ln":-71.21454,"country":"CA"},"followers":221},"tweet_id":"492681659704041474"}],"blogs":[{"title":"First Targeted Nanomedicine to Enter Human Clinical Studies is a Paradigm Shift in Anti-tumor Efficacy and Safety in Cancer Patients","url":"http:\/\/www.brighamandwomens.org\/about_bwh\/publicaffairs\/news\/pressreleases\/PressRelease.aspx?PageID=1114","license":"public","citation_ids":[4692659],"posted_on":"2012-04-04T00:00:00+00:00","summary":"Researchers have found promising effects of a first-in-class targeted cancer drug called BIND-014 in treating solid tumors.","author":{"name":"BWH Research News","url":"http:\/\/www.brighamandwomens.org\/","description":"Access the latest news from Brigham and Women's Hospital by subscribing to the RSS News feed. Brigham and Women's Hospital, a teaching affiliate of Harvard Medical School, is consistently ranked as one of the nation's leading hospitals. With one of the largest biomedical research institutes at any U.S. medical center, our clinical staff and research team work together to provide the public with advanced information and findings on virtually every area of medicine."}}]}}